Commercial insight into the pharma and biotech sector.

Solutions for Forecasting

As forecasting evolves to support strategic planning at the corporate level, benchmarking against credible external forecasts for company and sector performance and valuations is essential. EvaluatePharma’s forecasts are continuously updated providing a unique benchmark for your own forecasts against the consensus of the equity research community.

  • Benchmark internal forecasts against the consensus from leading equity research analysts to support your strategic planning 
  • Build credible models for future sector performance of products, pipelines and entire companies with our interactive NPV Analyzer
  • Model potential impact of industry events on product & company valuation with NPV Analyzer including patent extension, litigation & clinical trials
  • Access in-depth full financial models linked to business segment, product forecasts to 2016 & over 3100 global product NPVs
  • Rely with confidence on rigorous & consistent methodology with standardized, consistent reporting across geographies & business segments
  • Get unique insight into forecast changes with our unique catalogue of Archived Forecasts with 210,000 worldwide product sales forecasts from January 2003

Find out more Download Solutions for Forecasting

Register for access to a selection of free analysis and insights 


Exclusive Analysis & Insights

Global Market Analytics             Financial Information
Product Forecasts to 2016        Sales by Indication
Partnering Opportunities   Archived Sales Forecasts
Drug Information                         R&D Pipeline
Clinical Trials                     Venture Financing

Exclusive Analysis & Insights

Licensing Deals                               M&A Activity 
Patent Risk                                       NPV Analyzer
EP Vantage & EventAnalyzer          Calendar of Events
NewsManager                                 Peer Group Analyzer
Merge Company & Company Rank